About our research projects
Pre-clinical research
Pre-clinical, or early-stage, research is an important step in the drug discovery process as it provides the necessary evidence to move compounds into clinical trials. These studies are often laboratory-based, using models of Parkinson’s to provide information on drug safety and effectiveness, as well as to give insight on how a drug achieves its intended effect (also called the mechanism of action).
Cure Parkinson’s funds a number of pre-clinical studies, involving a variety of therapies and therapy targets. Additionally, an integral part of our mission is urgency. This means we only fund pre-clinical research that is likely to lead to clinical trials in people with Parkinson’s within five years.
Learn more about our pre-clinical projects
Other areas of interest
In addition to our clinical and pre-clinical research, Cure Parkinson’s also funds initiatives to improve and/or support Parkinson’s research in the UK. These include projects that aim to gather and improve patient experiences, foster environments for researchers to collaborate and communicate, and build platforms for streamlining trial recruitment.